| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |